Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase Interactions

REFERENCES

• Andrade, M. A., and P. Bork. 1995. HEAT repeats in the Huntington's disease protein. Nat. Genet. 11:115–116.
   PubMed Web of Science ®Google Scholar
• Chang, C. Y., and D. P. McDonnell. 2002. Evaluation of ligand-dependent changes in AR structure using peptide probes. Mol. Endocrinol. 16:647–660.
   PubMedGoogle Scholar
• Chen, F., K. Knecht, C. Leu, S. J. Rutledge, A. Scafonas, C. Gambone, R. Vogel, H. Zhang, V. Kasparcova, C. Bai, S. Harada, A. Schmidt, A. Reszka, and L. Freedman. 2004. Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol. J. Steroid Biochem. Mol. Biol. 91:247–257.
   PubMedGoogle Scholar
• Chen, J., J. Kim, and J. T. Dalton. 2005. Discovery and therapeutic promise of selective androgen receptor modulators. Mol. Interv. 5:173–188.
   PubMed Web of Science ®Google Scholar
• Cho, U. S., and W. Xu. 2006. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 445:53–57.
   PubMedGoogle Scholar
• Claessens, F., L. Celis, B. Peeters, W. Heyns, G. Verhoeven, and W. Rombauts. 1989. Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem. Biophys. Res. Commun. 164:833–840.
   PubMed Web of Science ®Google Scholar
• Cleutjens, K. B., H. A. van der Korput, C. C. van Eekelen, H. C. van Rooij, P. W. Faber, and J. Trapman. 1997. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11:148–161.
   PubMedGoogle Scholar
• Daaka, Y. 2004. G proteins in cancer: the prostate cancer paradigm. Sci. STKE 2004:re2.
   PubMedGoogle Scholar
• Dean, D. A., G. Urban, I. V. Aragon, M. Swingle, B. Miller, S. Rusconi, M. Bueno, N. M. Dean, and R. E. Honkanen. 2001. Serine/threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biol. 2:6.
   PubMedGoogle Scholar
• Defranco, D. B., A. P. Madan, Y. Tang, U. R. Chandran, N. Xiao, and J. Yang. 1995. Nucleocytoplasmic shuttling of steroid receptors. Vitam. Horm. 51:315–338.
   PubMed Web of Science ®Google Scholar
• DeFranco, D. B., M. Qi, K. C. Borror, M. J. Garabedian, and D. L. Brautigan. 1991. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol. Endocrinol. 5:1215–1228.
   PubMedGoogle Scholar
• DeLano, W. L. 2002. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA.
   Google Scholar
• Gaddipati, J. P., D. G. McLeod, H. B. Heidenberg, I. A. Sesterhenn, M. J. Finger, J. W. Moul, and S. Srivastava. 1994. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res. 54:2861–2864.
   PubMed Web of Science ®Google Scholar
• Gingrich, J. R., R. J. Barrios, M. W. Kattan, H. S. Nahm, M. J. Finegold, and N. M. Greenberg. 1997. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 57:4687–4691.
   PubMed Web of Science ®Google Scholar
• Gioeli, D., B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber. 2006. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 20:503–515.
   PubMed Web of Science ®Google Scholar
• Gioeli, D., S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, and M. J. Weber. 2002. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J. Biol. Chem. 277:29304–29314.
   PubMed Web of Science ®Google Scholar
• Groves, M. R., N. Hanlon, P. Turowski, B. A. Hemmings, and D. Barford. 1999. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96:99–110.
   PubMedGoogle Scholar
• Hammer, G. D., I. Krylova, Y. Zhang, B. D. Darimont, K. Simpson, N. L. Weigel, and H. A. Ingraham. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3:521–526.
   PubMed Web of Science ®Google Scholar
• Hatzoglou, A., M. Kampa, C. Kogia, I. Charalampopoulos, P. A. Theodoropoulos, P. Anezinis, C. Dambaki, E. A. Papakonstanti, E. N. Stathopoulos, C. Stournaras, A. Gravanis, and E. Castanas. 2005. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90:893–903.
   PubMed Web of Science ®Google Scholar
• He, B., N. T. Bowen, J. T. Minges, and E. M. Wilson. 2001. Androgen-induced NH2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2. J. Biol. Chem. 276:42293–42301.
   PubMed Web of Science ®Google Scholar
• Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417–439.
   PubMed Web of Science ®Google Scholar
• Joel, P. B., A. M. Traish, and D. A. Lannigan. 1998. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273:13317–13323.
   PubMed Web of Science ®Google Scholar
• Kasper, S., P. C. Sheppard, Y. Yan, N. Pettigrew, A. D. Borowsky, G. S. Prins, J. G. Dodd, M. L. Duckworth, and R. J. Matusik. 1998. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab. Investig. 78:i–xv.
   PubMedGoogle Scholar
• Kuil, C. W., and E. Mulder. 1995. Effects of androgens and antiandrogens on the conformation of the androgen receptor. Ann. N. Y. Acad. Sci. 761:351–354.
   PubMedGoogle Scholar
• Lange, C. A. 2004. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Mol. Endocrinol. 18:269–278.
   PubMedGoogle Scholar
• Langley, E., J. A. Kemppainen, and E. M. Wilson. 1998. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 273:92–101.
   PubMed Web of Science ®Google Scholar
• McDonnell, D. P. 2005. The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer. Clin. Cancer Res. 11:871s–877s.
   PubMed Web of Science ®Google Scholar
• McEwan, L. 2004. The nuclear receptor superfamily, vol. 40. Portland Press, London, United Kingdom.
   Google Scholar
• Murata, K., J. Wu, and D. L. Brautigan. 1997. B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 94:10624–10629.
   PubMedGoogle Scholar
• Nazareth, L. V., D. L. Stenoien, W. E. Bingman III, A. J. James, C. Wu, Y. Zhang, D. P. Edwards, M. Mancini, M. Marcelli, D. J. Lamb, and N. L. Weigel. 1999. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Mol. Endocrinol. 13:2065–2075.
   PubMedGoogle Scholar
• Nazareth, L. V., and N. L. Weigel. 1996. Activation of the human androgen receptor through a protein kinase A signaling pathway. J. Biol. Chem. 271:19900–19907.
   PubMed Web of Science ®Google Scholar
• Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167–176.
   PubMed Web of Science ®Google Scholar
• Porras, A., J. Bennett, A. Howe, K. Tokos, N. Bouck, B. Henglein, S. Sathyamangalam, B. Thimmapaya, and K. Rundell. 1996. A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J. Virol. 70:6902–6908.
   PubMed Web of Science ®Google Scholar
• Ruediger, R., M. Hentz, J. Fait, M. Mumby, and G. Walter. 1994. Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens. J. Virol. 68:123–129.
   PubMedGoogle Scholar
• Ruediger, R., D. Roeckel, J. Fait, A. Bergqvist, G. Magnusson, and G. Walter. 1992. Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol. Cell. Biol. 12:4872–4882.
   PubMedGoogle Scholar
• Shank, L. C., and B. M. Paschal. 2005. Nuclear transport of steroid hormone receptors. Crit. Rev. Eukaryot. Gene Expr. 15:49–73.
   PubMedGoogle Scholar
• Shao, D., and M. A. Lazar. 1999. Modulating nuclear receptor function: may the phos be with you. J. Clin. Investig. 103:1617–1618.
   PubMed Web of Science ®Google Scholar
• Shi, X. B., A. H. Ma, L. Xia, H. J. Kung, and R. W. de Vere White. 2002. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 62:1496–1502.
   PubMed Web of Science ®Google Scholar
• Somers, J. P., and D. B. DeFranco. 1992. Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. Mol. Endocrinol. 6:26–34.
   PubMedGoogle Scholar
• Taneja, S. S., S. Ha, N. K. Swenson, H. Y. Huang, P. Lee, J. Melamed, E. Shapiro, M. J. Garabedian, and S. K. Logan. 2005. Cell-specific regulation of androgen receptor phosphorylation in vivo. J. Biol. Chem. 280:40916–40924.
   PubMed Web of Science ®Google Scholar
• Tremblay, A., G. B. Tremblay, F. Labrie, and V. Giguere. 1999. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3:513–519.
   PubMed Web of Science ®Google Scholar
• Veldscholte, J., C. Ris-Stalpers, G. G. Kuiper, G. Jenster, C. Berrevoets, E. Claassen, H. C. van Rooij, J. Trapman, A. O. Brinkmann, and E. Mulder. 1990. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173:534–540.
   PubMed Web of Science ®Google Scholar
• Wang, Z., J. Frederick, and M. J. Garabedian. 2002. Deciphering the phosphorylation “code” of the glucocorticoid receptor in vivo. J. Biol. Chem. 277:26573–26580.
   PubMed Web of Science ®Google Scholar
• Weatherman, R. V., R. J. Fletterick, and T. S. Scanlan. 1999. Nuclear-receptor ligands and ligand-binding domains. Annu. Rev. Biochem. 68:559–581.
   PubMed Web of Science ®Google Scholar
• Wong, H. Y., J. A. Burghoorn, M. Van Leeuwen, P. E. De Ruiter, E. Schippers, L. J. Blok, K. W. Li, H. L. Dekker, L. De Jong, J. Trapman, J. A. Grootegoed, and A. O. Brinkmann. 2004. Phosphorylation of androgen receptor isoforms. Biochem. J. 383:267–276.
   PubMed Web of Science ®Google Scholar
• Xing, Y., Y. Xu, Y. Chen, P. D. Jeffrey, Y. Chao, Z. Lin, Z. Li, S. Strack, J. B. Stock, and Y. Shi. 2006. Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell 127:341–353.
   PubMed Web of Science ®Google Scholar
• Xu, Y., Y. Xing, Y. Chen, Y. Chao, Z. Lin, E. Fan, J. W. Yu, S. Strack, P. D. Jeffrey, and Y. Shi. 2006. Structure of the protein phosphatase 2A holoenzyme. Cell 127:1239–1251.
   PubMed Web of Science ®Google Scholar
• Yang, C. S., M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, and B. M. Paschal. 2005. Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor. Mol. Cell. Biol. 25:1298–1308.
   PubMedGoogle Scholar
• Zambrano, A., M. Kalantari, A. Simoneau, J. L. Jensen, and L. P. Villarreal. 2002. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 53:263–276.
   PubMed Web of Science ®Google Scholar
• Zhang, L., M. Johnson, K. H. Le, M. Sato, R. Ilagan, M. Iyer, S. S. Gambhir, L. Wu, and M. Carey. 2003. Interrogating androgen receptor function in recurrent prostate cancer. Cancer Res. 63:4552–4560.
   PubMedGoogle Scholar
• Zhang, Y., C. A. Beck, A. Poletti, J. P. t. Clement, P. Prendergast, T. T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel. 1997. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11:823–832.
   PubMedGoogle Scholar